These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 22298776)

  • 1. Insights into mechanism of glucokinase activation: observation of multiple distinct protein conformations.
    Liu S; Ammirati MJ; Song X; Knafels JD; Zhang J; Greasley SE; Pfefferkorn JA; Qiu X
    J Biol Chem; 2012 Apr; 287(17):13598-610. PubMed ID: 22298776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The active conformation of human glucokinase is not altered by allosteric activators.
    Petit P; Antoine M; Ferry G; Boutin JA; Lagarde A; Gluais L; Vincentelli R; Vuillard L
    Acta Crystallogr D Biol Crystallogr; 2011 Nov; 67(Pt 11):929-35. PubMed ID: 22101819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding kinetics of glucose and allosteric activators to human glucokinase reveal multiple conformational states.
    Antoine M; Boutin JA; Ferry G
    Biochemistry; 2009 Jun; 48(23):5466-82. PubMed ID: 19459610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical basis of glucokinase activation and the regulation by glucokinase regulatory protein in naturally occurring mutations.
    Heredia VV; Carlson TJ; Garcia E; Sun S
    J Biol Chem; 2006 Dec; 281(52):40201-7. PubMed ID: 17082186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational analysis of allosteric activation and inhibition of glucokinase.
    Zelent B; Odili S; Buettger C; Zelent DK; Chen P; Fenner D; Bass J; Stanley C; Laberge M; Vanderkooi JM; Sarabu R; Grimsby J; Matschinsky FM
    Biochem J; 2011 Dec; 440(2):203-15. PubMed ID: 21831042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of glucokinase by glucose, small-molecule activator and glucokinase regulatory protein: steady-state kinetic and cell-based analysis.
    Bourbonais FJ; Chen J; Huang C; Zhang Y; Pfefferkorn JA; Landro JA
    Biochem J; 2012 Feb; 441(3):881-7. PubMed ID: 22044397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting glucokinase activation for the treatment of type 2 diabetes--a status review.
    Sarabu R; Grimsby J
    Curr Opin Drug Discov Devel; 2005 Sep; 8(5):631-7. PubMed ID: 16159025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase and small chemical activators affect enzyme activity of activating glucokinase mutants by distinct mechanisms.
    Langer S; Hofmeister-Brix A; Waterstradt R; Baltrusch S
    Biochem Pharmacol; 2019 Oct; 168():149-161. PubMed ID: 31254492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research and development of glucokinase activators for diabetes therapy: theoretical and practical aspects.
    Matschinsky FM; Zelent B; Doliba NM; Kaestner KH; Vanderkooi JM; Grimsby J; Berthel SJ; Sarabu R
    Handb Exp Pharmacol; 2011; (203):357-401. PubMed ID: 21484579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phospho-BAD BH3 helix activates glucokinase by a mechanism distinct from that of allosteric activators.
    Szlyk B; Braun CR; Ljubicic S; Patton E; Bird GH; Osundiji MA; Matschinsky FM; Walensky LD; Danial NN
    Nat Struct Mol Biol; 2014 Jan; 21(1):36-42. PubMed ID: 24317490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-biological assessment of human glucokinase mutants causing maturity-onset diabetes of the young type 2 (MODY-2) or glucokinase-linked hyperinsulinaemia (GK-HI).
    Burke CV; Buettger CW; Davis EA; McClane SJ; Matschinsky FM; Raper SE
    Biochem J; 1999 Sep; 342 ( Pt 2)(Pt 2):345-52. PubMed ID: 10455021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent updates on glucokinase activators for the treatment of type 2 diabetes mellitus.
    Grewal AS; Sekhon BS; Lather V
    Mini Rev Med Chem; 2014; 14(7):585-602. PubMed ID: 25052034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular targeting of the GK-GKRP pathway in diabetes.
    Hale C; Lloyd DJ; Pellacani A; Véniant MM
    Expert Opin Ther Targets; 2015 Jan; 19(1):129-39. PubMed ID: 25324018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of glucokinase activators GKA50 and LY2121260 on proliferation and apoptosis in pancreatic INS-1 beta cells.
    Wei P; Shi M; Barnum S; Cho H; Carlson T; Fraser JD
    Diabetologia; 2009 Oct; 52(10):2142-50. PubMed ID: 19641898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose-induced conformational changes in glucokinase mediate allosteric regulation: transient kinetic analysis.
    Heredia VV; Thomson J; Nettleton D; Sun S
    Biochemistry; 2006 Jun; 45(24):7553-62. PubMed ID: 16768451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucokinase and glucose homeostasis: proven concepts and new ideas.
    Zelent D; Najafi H; Odili S; Buettger C; Weik-Collins H; Li C; Doliba N; Grimsby J; Matschinsky FM
    Biochem Soc Trans; 2005 Feb; 33(Pt 1):306-10. PubMed ID: 15667334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel, highly potent systemic glucokinase activators for the treatment of Type 2 Diabetes Mellitus.
    Xu J; Lin S; Myers RW; Addona G; Berger JP; Campbell B; Chen HS; Chen Z; Eiermann GJ; Elowe NH; Farrer BT; Feng W; Fu Q; Kats-Kagan R; Kavana M; Malkani S; McMasters DR; Mitra K; Pachanski MJ; Tong X; Trujillo ME; Xu L; Zhang B; Zhang F; Zhang R; Parmee ER
    Bioorg Med Chem Lett; 2017 May; 27(9):2069-2073. PubMed ID: 28284804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetrahydropalmatine from medicinal plants activates human glucokinase to regulate glucose homeostasis.
    Singh S; Ghosh P; Sharma S; Bhargava S; Kumar AR
    Biotechnol Appl Biochem; 2024 Apr; 71(2):295-313. PubMed ID: 38037220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermal stability of glucokinase (GK) as influenced by the substrate glucose, an allosteric glucokinase activator drug (GKA) and the osmolytes glycerol and urea.
    Zelent B; Buettger C; Grimsby J; Sarabu R; Vanderkooi JM; Wand AJ; Matschinsky FM
    Biochim Biophys Acta; 2012 May; 1824(5):769-84. PubMed ID: 22446163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucokinase activators for the potential treatment of type 2 diabetes.
    Grimsby J; Berthel SJ; Sarabu R
    Curr Top Med Chem; 2008; 8(17):1524-32. PubMed ID: 19075763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.